Has humanity defeated ageing? Scientists strike 'single pill' breakthrough

Scientists have achieved a major breakthrough in combating ageing and age-related diseases. The study by the researchers from Harvard Medical School andMassachusetts Institute of Technology was published in the journal Aging-US.

Humanity's attempt to prevent ageing: What is the breakthrough?

The researchers have introduceda chemical method through a 'single pill' to reprogram body cells, following which the cells effectively return to a younger state.

Add WION as a Preferred Source

This achievement represents a significant advancement, as previously only gene therapy could achieve similar results.

The researchers reportedly built upon the Nobel Prize-winning discovery in 2012 that certain genes, known as Yamanaka factors, could transform adult cells into pluripotent stem cells which haveunlimited capacity to divide, self-renew and differentiate into cells of early primary germ cell layers, namely mesoderm, endoderm, and ectoderm.

Challenges faced by researchers

The key challenge was to reverse cellular ageing without triggering cancerous growth.

Lead scientist David A. Sinclair, a Professor in the Department of Genetics at Harvard, expressed the significance of this achievement, stating that while aging could previously only be slowed down, it can now potentially be reversed.

Also watch |Gravitas: A step closer to anti-ageing drugs

"This new discovery offers the potential to reverse ageing with a single pill, with applications ranging from improving eyesight to effectively treating numerous age-related diseases," Sinclair said.

He noted that this breakthrough eliminates the need for gene therapy, which had limited accessibility.

The implications of this discovery are extensive, offering new possibilities for regenerative medicine and the potential for whole-body rejuvenation.

What does it mean for humanity?

By developing a chemical alternative to gene therapy for age reversal, this research has the potential to revolutionise the treatment of ageing, injuries, and age-related diseases, leading to reduced costs and shorter development timelines.

Human clinical trials for the lab's age-reversal gene therapy are now being prepared, following successful efforts to reverse blindness in monkeys in April 2023.

The Harvard team envisions a future where age-related diseases can be effectively treated, injuries can be efficiently repaired, and the dream of whole-body rejuvenation becomes a reality.

WATCH WION LIVE HERE

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.